Today: 10 April 2026
Unilever shares slip in London as Reuters flags India slowdown ahead of earnings
13 January 2026
1 min read

Unilever shares slip in London as Reuters flags India slowdown ahead of earnings

London, Jan 13, 2026, 08:20 GMT — Regular session

  • Unilever slipped 0.22% in early trading Tuesday in London
  • Reuters Breakingviews highlights the squeeze on pricing power in India amid rising competition
  • Investors are eyeing Unilever’s Feb. 12 earnings report for clues on growth and margin trends

Unilever’s shares slipped 0.22% to 4,760 pence by 08:07 GMT Tuesday, following a close of 4,770.5 pence on Monday. The stock has dropped nearly 2% over the last year and offers a trailing dividend yield of around 3.7%, LSEG data shows. markets.investorschronicle.co.uk

European shares hit a record high, amid caution ahead of U.S. inflation figures due later that day. Investors eyed the data closely, knowing it could shift rate expectations and sway “everyday goods” stocks alongside broader market trends. Reuters

A Reuters Breakingviews column late Monday highlighted that Unilever and Nestlé are losing pricing power in India. The rise of fast-delivery apps and emerging local brands is eroding their traditional distribution advantage. According to the piece, Hindustan Unilever’s sales rose just 2% in the year ending March 2025. EBITDA margins — which roughly track operating profit before interest, tax, and some non-cash costs — are projected by Visible Alpha to remain below pandemic highs through at least 2027. The article notes India makes up around 11% of Unilever’s sales. Reuters

That strikes a chord since India has often buffered weaker demand from Europe and the US. If that buffer shrinks, investors will dig deeper, questioning how much of the growth is genuine and how much just reflects pricing.

The squeeze comes as consumer groups aim to appear leaner and more focused, shedding what they call dead weight in their portfolios. At least, that’s the sales pitch.

Unilever wrapped up the demerger of its ice cream division in early December, spinning off the new entity as The Magnum Ice Cream Company. This shift changes the company’s structure and sets fresh expectations for investors. Investegate

Traders are focused on one key question: can Unilever continue raising prices without losing market share, particularly in emerging markets where consumers are more cautious and alternatives are just a click away.

The downside isn’t straightforward. If inflation eases and promotional wars die down, worries over margins could vanish fast — and those same brands that seem worn out during a slump often bounce back once spending revives.

Peers are caught in a similar push and pull. Nestlé stands out for its India exposure, while Reckitt and Procter & Gamble attract attention from investors eyeing the staples sector as a whole rather than individual names.

Unilever’s Q4 and full-year 2025 results drop on Feb. 12, with the company set to speak at the CAGNY Conference five days later on Feb. 17. These events promise updated data and insight into management’s outlook on India, pricing strategies, and spending plans for 2026. Unilever

Stock Market Today

  • China's Oricell Therapeutics Secures $100M Pre-IPO Funding for Carcinoma CAR-T Development
    April 10, 2026, 4:55 AM EDT. Shanghai-based Oricell Therapeutics raised over $100 million in its latest pre-IPO financing round to advance development of its CAR-T therapies targeting carcinoma. The funding, led by Vivi Capital, Beijing Medical and other major investors, will support Oricell's clinical trials and global expansion. Its lead candidate, Ori-C101, targets hepatocellular carcinoma (HCC) and showed promising results in a Phase 1 study with positive responses at the highest dose. Oricell aims to become the first to globally approve a CAR-T treatment for HCC. The company also pushes forward with next-gen modalities including in vivo CAR-T, a cutting-edge therapy approach. Founded in 2015, Oricell has raised significant capital ahead of its planned IPO.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 4:55 AM EDT China's Oricell Therapeutics Secures $100M Pre-IPO Funding for Carcinoma CAR-T Development April 10, 2026, 4:55 AM EDT. Shanghai-based Oricell Therapeutics raised over $100 million in its latest pre-IPO financing round to advance development of its CAR-T therapies targeting carcinoma. The funding, led by Vivi Capital, Beijing Medical and other major investors, will support Oricell's clinical trials and global expansion. Its lead candidate, Ori-C101, targets hepatocellular carcinoma (HCC) and showed promising results in a Phase 1 study with positive responses at the highest dose. Oricell aims
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Rio Tinto stock ticks up in London as BHP steps back from Glencore bid talk
Previous Story

Rio Tinto stock ticks up in London as BHP steps back from Glencore bid talk

Diageo shares jump on China asset-sale report as investors eye Feb results
Next Story

Diageo shares jump on China asset-sale report as investors eye Feb results

Go toTop